Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atropine for Preventing Ventilator-Associated Pneumonia
NCT02704923Phase 2Completed
- Sponsor
- Universidade de Passo Fundo
- Start
- Feb 2015
- Primary completion
- Dec 2015
- Modality
- Small Molecules, Drug Delivery Systems
01
Overview
Phase 2, randomised, double-blind trial of NVK002 in ventilator-associated pneumonia (VAP) (2 arms), sponsored by Universidade de Passo Fundo. Primary endpoint: Ventilator-Associated Pneumonia at 1 year. Started Feb 2015; status: completed.
02
Drugs
NVK002
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on NCT02704923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02704923.